Diagnostica Stago, Inc.
5 Century Dr, PARSIPPANY, NJ, US
Registered product codes
32 product codes
Recent MDR events
11 on file
- STA LIATEST D-DIOct 3, 2025InjuryMW5176883
- STAGO STA COMPACT MAXJun 2, 2025InjuryMW5170914
- STAGO EVOLUTIONJan 17, 2019MalfunctionMW5083226
- DESTINY MAXSep 1, 2015Injury5044599
- STA COMPACTDec 26, 2013Malfunction2245451-2013-00002
- STAGOJun 2, 2011InjuryMW5020902
- STA COMPACTFeb 21, 2007Malfunction822243
- DIAGNOSTIC STAGOSep 20, 2004Other2245451-2004-00002
- COMPACTSep 10, 2004Other549982
- STA COMPACT HEMOSTASIS SYSTEMSep 7, 2004Malfunction2245451-2004-00001
Recalls
41 on file
- Open, ClassifiedMar 19, 2026
After receiving customer complaints, investigations confirmed the presence of a positive bias in D-Dimer measurements throughout the entire analytical range.
View FDA record ↗ - Open, ClassifiedMar 3, 2026
The potential of out-of-range results and an underestimation of the free protein S level in normal patient plasmas. The defect only affects normal-range values.
View FDA record ↗ - Open, ClassifiedJan 14, 2026
Potential for defect for Asserachrom HPIA lot 271288, which can affect every well in the impacted strip and produce negative results.
View FDA record ↗ - Open, ClassifiedOct 16, 2025
A potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots.
View FDA record ↗ - Open, ClassifiedAug 28, 2025
Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.
View FDA record ↗ - Open, ClassifiedAug 28, 2025
Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.
View FDA record ↗ - Open, ClassifiedAug 28, 2025
Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.
View FDA record ↗ - Open, ClassifiedAug 28, 2025
Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.
View FDA record ↗ - Open, ClassifiedJun 18, 2025
Potential for shorter clotting times in clotting tests which have a dilution, leading to possible overestimate of around 1%
View FDA record ↗ - Open, ClassifiedMay 10, 2023
An internal investigation identified a bug in this firmware version, resulting in the following:Intermittent shortened coagulation times and an increased frequency of occurrence of a technical error reported by the analyzer (error 13).
View FDA record ↗
Compliance history
Matched by FEI 2245451.
FDA inspections
4 on file
- No Action Indicated (NAI)Sep 9, 2025
Compliance: Devices
- No Action Indicated (NAI)Sep 9, 2025
Postmarket Assurance: Devices
- Voluntary Action Indicated (VAI)Sep 4, 2024
Compliance: Devices · Citations posted
- Voluntary Action Indicated (VAI)Sep 4, 2024
Postmarket Assurance: Devices · Citations posted
Inspection citations
1 on file
Top cited requirements
Compare to industry ↗- 21 CFR 803.17Sep 4, 2024
Lack of Written MDR Procedures
Compliance actions
0 on file
No warning letters or injunctions on file for this FEI number.
Import refusals
0 on file
No import refusals on file for this FEI number.